Clinical trials
Observational Myelodysplastic Syndromes trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cooperative Study Group A for Hematology | 2 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 2 |
| Istituto Clinico Humanitas | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Grenoble | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Celgene Corporation | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| European Working Group of MDS in Childhood | 1 |
| Fondazione Amelia Scorza Onlus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 35 |
| Leukemia, Myeloid, Acute | 8 |
| Leukemia | 4 |
| Anemia, Aplastic | 3 |
| Anemia | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Purpura, Thrombocytopenic | 2 |
| Anemia, Sickle Cell | 1 |
| Bone Marrow Failure Disorders | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.